Genmab — April 2020

[GeorgeBest]

Kayne Anderson Rudnick Investment Management LLC increased its stake in Genmab A/S by 0.9% in the fourth quarter. Kayne Anderson Rudnick Investment Management LLC now owns 127,189 shares of the company's stock valued at $2,840,000 after purchasing an additional 1,170 shares during the last quarter. Finally, Assetmark Inc. boosted its holdings in shares of Genmab A/S by 28.6% in the fourth quarter.

[GeorgeBest]

Assetmark Inc. now owns 5,301 shares of the company's stock valued at $118,000 after acquiring an additional 1,180 shares during the period. Institutional investors and hedge funds own 3.64% of the company's stock.

[Mcjean]

You forgot ........Esbjerg Havns pølsemands Investment Management LLC have increase it shares by 15% and own now more than before. Esbjergs Pølsemandsdaughters Invest Management LLC have increase there shares with 2 and therefore have a buyrating on the stock say the "Journal Vi Unge".

[JKY_VH]

[Helge_LarsenPI-redaktør]

Skåret kop med hank set på pølsemandens disk ved siden af chilli-mayoen: https://www.proinvestor.com/debat/83797

[Legolas23]

Jeg er overbevist om, vi får en fantastisk god nyhed i løbet af weekenden...

[troldmanden]

Og hvad skulle det så være?

[E_L]

i can only read the headline , but maybe it is of use for any of
you
https://dagensmedicin.dk/salget-af-darzalex-boomer/

[fillipa]

Ved nogen hvorfor der ikke kan handles Gen 2N certificat hos Nordea får svar om at den ikke udbydes mere....

[nohope]

EL - you can get 14 days access for free at Dagens Medicin.(Unless you have already done that recently)

[fillipa]

Ok tak og det er ikke der er til udløb har du evt en ISINkode til den .....

[fillipa]

Tænker det stort set er samme certicat

[fillipa]

tusind tak god dag

[E_L]

@nohope thks- but i like the headline so much, don't need to read more

[nohope]

I love your attitude Just the right attitude whenever you are doing in new medicne, if the preliminair news are good - then just stop investigating.

[E_L]

haha, any hint to Remdesivir in there?

[E_L]

https://www.nature.com/articles/s41375-020-0810-4 Nature: Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting full art https://sci-hub.tw/https://www.nature.com/articles/s41375-020-0810-4

[E_L]

https://sci-hub.tw/https://www.nature.com/articles/s41375-020-0810-4

[E_L]

@peter i am not sure, it is a bit confusing as clinical trials still mentions Ph I , and it was only last September that they added lazertinib to the trial

[Sukkeralf]

in cancer trials you normaly calls it phase 1/2 because you always treat patients right away. Genmab got daratumumab approved in third line Dara/POM/Dex based on phase 1/2 data